AI-generated summary
The authors reviewed seven randomized controlled trials involving 337 women to evaluate laser therapies for vulvar lichen sclerosus compared with other treatments. Five trials reported symptom improvement after laser therapy, but results were heterogeneous and not consistently better than comparators, and the only sham-controlled trial showed no advantage of fractional CO2 laser over sham. The authors note small cohorts and methodological heterogeneity and call for larger sham-controlled trials.
- Participants
- 337
- Studies included
- 7
- Who or what was studied
- Women with vulvar lichen sclerosus (seven randomized controlled trials, 337 women)
- Limits stated in the abstract
- The authors note small cohorts, methodological heterogeneity, and that the only sham-controlled trial did not show superiority of fractional CO2 laser over sham.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Systematic review, Sham, Heterogeneity, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.